Lee Ainslie’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-10,727
Closed -$1.34M 447
2021
Q3
$1.34M Buy
10,727
+9,939
+1,261% +$1.18M 0.01% 231
2021
Q2
$98K Buy
+788
New +$106K ﹤0.01% 567
2021
Q1
Sell
-1,599
Closed -$206K 767
2020
Q4
$206K Buy
+1,599
New +$184K ﹤0.01% 523

Other funds holding GH

Lee Ainslie's GH Position: Q4 2021 in Review

Lee Ainslie sold out of Guardant Health (GH) in Q4 2021, closing a stake of 10,727 shares — an estimated $1.34M sold.

Lee Ainslie first reported a position in GH in Q4 2020 and held it in 3 quarters. The position peaked at $1.34M in Q3 2021. 396 funds tracked by Wall St. Rank hold GH as of Q4 2021.

  • Lee Ainslie reported no remaining Guardant Health position as of Q4 2021 after selling out during the quarter.
  • Lee Ainslie sold 10,727 Guardant Health shares in Q4 2021, an estimated $1.34M.
  • Lee Ainslie first reported a position in Guardant Health in Q4 2020 and held it in 3 quarters.
  • Lee Ainslie's Guardant Health position peaked at $1.34M in Q3 2021.
  • 396 funds tracked by Wall St. Rank held Guardant Health as of Q4 2021.

Based on Maverick Capital's 13F filing for Q4 2021, filed 14 Feb 2022.